Inactive Instrument
Sector dividends Intercept Pharmaceuticals, Inc.
Stocks
ICPT
US45845P1084
Biotechnology & Medical Research
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | - | - | - | 795M | |
| 1.5% | 1.7% | 21.25x | 4.11x | 6.51x | 14.24x | 16.4x | 56.54B | |
| 0.05% | 0.09% | 31.6x | 6x | 7.8x | 24.02x | 24.51x | 53.6B | |
| -.--% | -.--% | -17.91x | 1.1x | 4.18x | -7.32x | -6.17x | 22.91B | |
| -.--% | -.--% | -38.06x | 49.84x | 12.21x | -36.05x | -39.76x | 21.37B | |
| -.--% | -.--% | 25.45x | 2.49x | 4.98x | 13.18x | 15.76x | 20.27B | |
| -.--% | -.--% | 24.28x | 2.75x | 4.73x | 15.36x | 17.32x | 17.56B | |
| -.--% | -.--% | -737.38x | 18.22x | 35.03x | -3943.97x | -495.61x | 14.75B | |
| 0.09% | 0.14% | 40.7x | 10.44x | 16.37x | 42.16x | 38.68x | 13.53B | |
| -.--% | -.--% | 16.73x | 4.75x | 4.82x | 11.24x | 12.14x | 13.33B | |
| -.--% | -.--% | -26.07x | 28.14x | 24.96x | -31.27x | -24.97x | 11.92B | |
| -.--% | 0.03% | -5064.4x | 7.82x | 13.72x | 91.49x | 407.38x | 11.04B | |
| -.--% | -.--% | -74.01x | 24.05x | 6.75x | -55.74x | -54.56x | 10.8B | |
| -.--% | -.--% | -12.07x | -83.8x | 87.58x | -13.65x | -13.27x | 10.47B | |
| -.--% | -.--% | -10.72x | 38.23x | 2390.94x | -12.67x | -11.01x | 10.39B | |
| -.--% | -.--% | -32x | 8.79x | - | -29.57x | -28.61x | 8.65B | |
| -.--% | -.--% | 11.62x | 5.71x | 7.27x | 11.67x | 10.81x | 8.08B | |
| Average | 0.1% | 0.12% | -365.06x | 8.04x | 175.19x | -244.18x | -8.18x | 18B | |
| Weighted average by Cap. | 0.29% | 0.34% | -212.67x | 8.32x | 95.97x | -183.98x | -5.09x |
